- Home
- CRON vs DLY Comparison
CRON vs DLY Comparison
Compare CRON & DLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRON
- DLY
- Stock Information
- Founded
- CRON 2012
- DLY 2019
- Country
- CRON Canada
- DLY United States
- Employees
- CRON N/A
- DLY N/A
- Industry
- CRON Medicinal Chemicals and Botanical Products
- DLY Investment Managers
- Sector
- CRON Health Care
- DLY Finance
- Exchange
- CRON Nasdaq
- DLY Nasdaq
- Market Cap
- CRON 707.7M
- DLY 790.9M
- IPO Year
- CRON N/A
- DLY N/A
- Fundamental
- Price
- CRON $1.79
- DLY $16.06
- Analyst Decision
- CRON Hold
- DLY
- Analyst Count
- CRON 2
- DLY 0
- Target Price
- CRON $3.00
- DLY N/A
- AVG Volume (30 Days)
- CRON 1.4M
- DLY 215.9K
- Earning Date
- CRON 05-08-2025
- DLY 01-01-0001
- Dividend Yield
- CRON N/A
- DLY 8.93%
- EPS Growth
- CRON N/A
- DLY N/A
- EPS
- CRON 0.11
- DLY N/A
- Revenue
- CRON $117,615,000.00
- DLY N/A
- Revenue This Year
- CRON $22.27
- DLY N/A
- Revenue Next Year
- CRON $7.36
- DLY N/A
- P/E Ratio
- CRON $16.68
- DLY N/A
- Revenue Growth
- CRON 34.82
- DLY N/A
- 52 Week Low
- CRON $1.77
- DLY $13.26
- 52 Week High
- CRON $3.14
- DLY $15.95
- Technical
- Relative Strength Index (RSI)
- CRON 35.67
- DLY 42.67
- Support Level
- CRON $1.78
- DLY $15.96
- Resistance Level
- CRON $1.84
- DLY $16.23
- Average True Range (ATR)
- CRON 0.06
- DLY 0.10
- MACD
- CRON -0.01
- DLY -0.01
- Stochastic Oscillator
- CRON 4.55
- DLY 30.37
About CRON Cronos Group Inc. Common Share
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest
DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.